June 20, 2019
Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) on Wednesday formally introduced a wide-ranging bill to address so-called "surprise" medical bills that would establish a benchmark provider payment rate for out-of-network services, instead of the arbitration process favored by hospital industry groups.
Tufts Medical Center in April 2018 received almost 5,000 scam phone calls in two hours, bringing communications at the hospital to a standstill—and it is not the only health care provider to be hit with such calls.
Valisure, an online pharmacy, in a filing to FDA last week said it discovered the carcinogen dimethylformamide in the common heart drug valsartan—marking the fourth carcinogen found in the drug.
CMS on Monday proposed a rule intended to streamline Medicare Part D's electronic prior authorization process by circumventing certain HIPAA requirements.
June 19, 2019
U.S. residents increasingly are visiting Canada to purchase insulin, as costs for the diabetes treatment in the United States have spiked in recent years.
About 169.1 million doses of the seasonal influenza vaccine were administered last flu season, and about 200 patients received expired vaccines—though the real figure might be higher, according to a CDC report published Friday.
June 18, 2019
CMS Administrator Seema Verma in August 2018 warned HHS Secretary Alex Azar against three policy changes that she estimated would decrease Affordable Care Act exchange enrollment by 1.1 million and jeopardize the exchange market, according to an internal memo.
The number of measles cases reported in the United States this year has continued to grow, and state and local health departments—which are largely responsible for tracking, reporting, and combating measles outbreaks—are feeling strained.
FDA on Thursday warned providers and patients of the potential life-threatening risks of fecal microbiota transplants (FMT), after a patient who received an FMT was infected with a drug-resistant bacteria and died.
June 17, 2019
Three pharmaceutical companies and the Association of National Advertisers on Friday filed a lawsuit challenging HHS' final rule to require drugmakers to disclose their products' list prices in consumer-directed television advertisements, claiming the final rule exceeds HHS' statutory authority and violates the First Amendment of the Constitution.
Advisory Board. All rights reserved.